Inicio › Lupus › Texas › Houston
Ensayos clínicos de Lupus en Houston, TX
14 estudios para Lupus buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
ReclutandoFase 3
- Research Site, Houston
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
ReclutandoFase 2
- The University of Texas Health Science Center at Houston, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
ReclutandoEstudio observacional
- M D Anderson Cancer Center, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
ReclutandoFase 1
- UT MD Anderson Cancer Center, Houston
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
ReclutandoFase 3
- Novel Research LLC, Bellaire · A 7 mi de distancia
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
ReclutandoFase 3
- Prolato Clinical Research Center, Houston
- Accurate Clinical Research, Humble · A 17 mi de distancia
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
ReclutandoFase 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
ReclutandoFase 3
- Sl0044 50696, Houston
- Sl0044 50723, Houston
- Sl0044 50738, Bellaire · A 7 mi de distancia
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
ReclutandoFase 2
- Texas Children's Hospital, Houston
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
ReclutandoFase 1
- Baylor College of Medicine, Houston
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
ReclutandoFase 1
- Accurate Clinical Research - Houston /ID# 278382, Houston
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
ReclutandoFase 1/2
- University of Texas MD Anderson Cancer Center, Houston
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
ReclutandoFase 3
- Research Site, Houston
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
ReclutandoFase 3
- Novel Research, LLC., Houston
- Northwest Houston Arthritis, Houston
- Rheumatology Care Center, PLLC, Bellaire · A 7 mi de distancia
Más información sobre Lupus en MedlinePlus
Ensayos de Lupus en otras ciudades
- New York City, NY18 estudios
- Durham, NC12 estudios
- Washington, DC11 estudios
- Miami, FL10 estudios
- Oklahoma City, OK9 estudios
- San Diego, CA8 estudios
- Tampa, FL8 estudios
- Boston, MA8 estudios
- Chicago, IL8 estudios
- Philadelphia, PA8 estudios
- Santa Monica, CA7 estudios
- Plantation, FL7 estudios
Otros estudios en Houston
- Cáncer de pulmón de células no pequeñas143 estudios
- Cáncer de seno126 estudios
- Cáncer (todos los tipos)124 estudios
- Cáncer del colon y del recto101 estudios
- Cáncer metastásico100 estudios
- Cáncer de ovario90 estudios
- Leucemia mielógena aguda88 estudios
- Cáncer de pulmón78 estudios
- Cáncer de próstata73 estudios
- Cáncer de endometrio69 estudios
- Melanoma61 estudios
- Cáncer de páncreas59 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.